Levocetirizine Dihydrochloride Tablet
Product Images NDC 0615-8565

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Levocetirizine Dihydrochloride (NDC 0615-8565). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ncs Healthcare Of Ky, Llc Dba Vangard Labs, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Levocetirizine Dihcl Tabs 8565 1)

FDA Label Image

Principal Display Panel (Levocetirizine Dihcl Tabs 8565 2)

Principal Display Panel (Levocetirizine Dihcl Tabs 8565 2)
This is a description that includes information about a medication called Levocetirizine Dihydrochloride Tablets, USP 5 mg. The tablets are film-coated and each tablet contains Levocetirizine dihydrochloride, USP 5 mg. The manufacturing company is ScieGen. The storage instructions advise keeping the tablets at 20°C to 25°C (68°F to 77°F). The usual dosage and prescribing information should be checked on the package insert. The medication is for institutional use only. The tablets have a LOT number of 8565 and come in packages produced by Vangard in Glasgow, KY.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.